Literature DB >> 12879324

Neuro-Behçet's disease: analysis of apparent diffusion coefficients.

A Kunimatsu1, O Abe, S Aoki, N Hayashi, T Okubo, T Masumoto, H Mori, T Yoshikawa, H Yamada, K Ohtomo.   

Abstract

Little is known about the diffusion properties of brain lesions in neuro-Behçet's disease (NBD). We looked at 19 NBD lesions (13 active, six chronic) in six patients, using diffusion-weighted MRI (DWI). We calculated the apparent diffusion coefficients (ADC) of the lesions and compared them with normal contralateral brain, expressing this ratio as relative ADC (rADC). The rADC was 1.29+/-0.33 in active and 1.44+/-0.47 in chronic lesions, i.e., significantly higher than in the control regions. Increased diffusivity in both active and chronic phases in NBD is different from the pattern in ischaemic infarcts, so that ADC analysis might be helpful for differentiating between these conditions.

Entities:  

Mesh:

Year:  2003        PMID: 12879324     DOI: 10.1007/s00234-002-0890-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Diffusion weighted magnetic resonance imaging in Neuro-Behçet's disease.

Authors:  D W Kang; K Chu; J Y Cho; J S Koo; B W Yoon; J K Roh; I C Song; K H Chang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke.

Authors:  G Schlaug; B Siewert; A Benfield; R R Edelman; S Warach
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  INVOLVEMENT OF NERVOUS SYSTEM IN BEHCET'S SYNDROME.

Authors:  S M WOLF; D L SCHOTLAND; L L PHILLIPS
Journal:  Arch Neurol       Date:  1965-03

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  A simplified method to measure the diffusion tensor from seven MR images.

Authors:  P J Basser; C Pierpaoli
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

Review 6.  Perspectives on multiple sclerosis.

Authors:  R I Grossman; J C McGowan
Journal:  AJNR Am J Neuroradiol       Date:  1998-08       Impact factor: 3.825

7.  MRI findings in neuro-Behçet's disease.

Authors:  M Z Al Kawi; S Bohlega; M Banna
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

8.  [Diffusion-weighted magnetic resonance imaging of neuro-Behçet's disease].

Authors:  K Ohta; K Obara; H Sato; T Iguchi; N Suzuki
Journal:  Rinsho Shinkeigaku       Date:  2000-04

9.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions.

Authors:  A L Tievsky; T Ptak; J Farkas
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

10.  Long-term MR follow-up of cerebral lesions in neuro-Behçet's disease.

Authors:  S Gerber; A Biondi; D Dormont; B Wechsler; C Marsault
Journal:  Neuroradiology       Date:  1996-11       Impact factor: 2.804

View more
  4 in total

1.  Reversibility of brain lesions in a case of Neuro-Behçet's disease studied by MR diffusion.

Authors:  Luisa Vuolo; Laura Bonzano; Caterina Roccatagliata; Roberto Carlo Parodi; Luca Roccatagliata
Journal:  Neurol Sci       Date:  2010-01-30       Impact factor: 3.307

2.  Different diffusion-weighted MRI findings in brainstem neuro-Behçet's disease.

Authors:  Sema Yildiz; Nurefsan Boyaci; Dilek Sen Dokumaci; Ahmet Boyaci
Journal:  BMJ Case Rep       Date:  2013-09-12

3.  Diffusion-weighted imaging in chronic Behçet patients with and without neurological findings.

Authors:  T Baysal; M Dogan; R Karlidag; H I Ozisik; O Baysal; T Bulut; K Sarac
Journal:  Neuroradiology       Date:  2005-05-26       Impact factor: 2.804

4.  Brain perfusion MRI findings in patients with Behcet's disease.

Authors:  Alpay Alkan; Asli Goktan; Yelda Karincaoglu; Suat Kamisli; Metin Dogan; Namik Oztanir; Nergiz Turan; Ercan Kocakoc
Journal:  ScientificWorldJournal       Date:  2012-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.